Vir Biotechnology, Inc. VIR Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s common stock, shares, outstanding?
- Vir Biotechnology, Inc. (VIR) reported common stock, shares, outstanding of $161.23M in Q1 2026.
- How has Vir Biotechnology, Inc.'s common stock, shares, outstanding changed year-over-year?
- Vir Biotechnology, Inc.'s common stock, shares, outstanding increased by 16.8% year-over-year, from $138.06M to $161.23M.
- What is the long-term trend for Vir Biotechnology, Inc.'s common stock, shares, outstanding?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s common stock, shares, outstanding has grown at a 1.5% compound annual growth rate (CAGR), from $133.24M to $139.47M.